Keywords: fda, approves, accelerated, dosing, schedule, gsk, twinrix

FDA approves accelerated dosing schedule for GSK's Twinrix

Article | 09 April 2007

Print This

UK drug major GlaxoSmithKline says that the US Food and Drug Administration has approved Twinrix (inactivated hepatitis A vaccine and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in